Richard Nathan
- Epidemiology top 5%
- Infectious Diseases top 10%
- Immunology
- Health top 5%
- Molecular Biology
- Co-authors
- Richard PollakVictoria LandolfiAndrew J. DunningAvi CollinsNadia TornieporthJohn EarlJohn J. TreanorDaniel Kirby
- Topics
- Clostridium difficile and Clostridium perfringens research (5 papers)Viral gastroenteritis research and epidemiology (2 papers)Microscopic Colitis (2 papers)
- Journals
- New England Journal of MedicineVaccinePharmacotherapy The Journal of Human Pharmacology and Drug Therapy
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Richard Nathan
7 papers receiving 653 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Epidemiology 526
- Infectious Diseases 239
- Immunology 119
- Health 113
- Molecular Biology 54
Countries citing papers authored by Richard Nathan
This map shows the geographic impact of Richard Nathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Nathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Nathan more than expected).
Fields of papers citing papers by Richard Nathan
This network shows the impact of papers produced by Richard Nathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Nathan. The network helps show where Richard Nathan may publish in the future.
Co-authorship network of co-authors of Richard Nathan
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Nathan. A scholar is included among the top collaborators of Richard Nathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Nathan. Richard Nathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 9 | |
| 3 | 9 | |
| 4 | 76 | |
| 5 | 15 | |
| 6 | Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adultsbreakdown → | 549 |
| 7 | 5 |
About Richard Nathan
Richard Nathan is a scholar working on Infectious Diseases, Microbiology and Clinical Biochemistry, having authored 7 papers that have together received 666 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (5 papers), Viral gastroenteritis research and epidemiology (2 papers) and Microscopic Colitis (2 papers). The work is most often cited by research in Epidemiology (526 citations), Health (113 citations) and Infectious Diseases (239 citations). Richard Nathan has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Richard Pollak, Victoria Landolfi, Andrew J. Dunning, Avi Collins, Nadia Tornieporth, John Earl, John J. Treanor, Daniel Kirby, Murray Kimmel and Carlos A. DiazGranados. Their work appears in journals such as New England Journal of Medicine, Vaccine and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.